RPG Life Sciences
 |
|
| Public | |
| Industry | Pharmaceuticals, Bio Technology |
| Founded | 1993 |
| Headquarters | Mumbai, Maharashtra, India |
|
Key people
|
Ajit S. Chouhan, Managing Director |
| Revenue | INR 163 crores (March 2010) |
| Parent | RPG Enterprises |
| Website | www.rpgls.com |
Ajit S. Chouhan, Managing Director
Rajindrra Patkar, Chief Executive - Global Formulations
V K Singh, Chief Executive - Global Generics, API & Biotech
Sachin Raole, Senior Vice President - Finance
RPG Life Sciences (RPGLS) is an Indian Pharmaceutical Company. Formerly known as Searle (India) Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are manufacturing and marketing of bulk drugs, also known as API, (Active Pharmaceutical Ingredients), pharmaceutical formulation and fermentation & biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia & South East Asian countries.
Earlier known as Searle India Ltd, RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The company’s name was changed to RPG Life Sciences Ltd effective 1 April 1999. The company was in the business of Pharmaceuticals and Agrochemicals. It divested the Agrochemicals business in the year 2001, as per the strategic decision to focus on Pharmaceuticals, Fermentation and Biotechnology.
RPGLS has presence in healthcare, bio-technology, bulk drugs and generic business.
Three major activities of RPGLS are Manufacturing and marketing of bulk drugs (synthetic Active Pharmaceutical Ingredients) & formulations internationally, pharmaceutical formulations & domestic marketing, and fermentation & biotechnology.
The Healthcare division is divided into the Sertec and Acumed Speciality Divisions. The former manufactures medications for "Critical & Chronic" ailments and the latter for Chronic. The third division Medillion markets generic formulations. A separate laboratory with qualified people in chemical engineering and physical chemistry is provided to develop newer and more efficient formulations.
The Bio Technology business mainly focuses on fermentation products. The fermentation division was set up in 1998 as a new arm of the company to exclusively cater to high-value life saving drugs produced by fermentation route using biotechnology. The division has established itself in markets in India and overseas for its APIs and finished dosage forms. It exports its product in the markets Brazil, Mexico, Ukraine & Baltic States, Dominican Republic, Peru, S. Korea, China, Argentina.
Operations of RPGLS is divided mainly into pharmaceutical formulation and Fermentation and Biotechnology.
...
Wikipedia